Published in Sci Rep on February 08, 2016
Placental ABC Transporters: Biological Impact and Pharmaceutical Significance. Pharm Res (2016) 0.79
Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A (2003) 4.41
Molecular imaging in drug discovery and development. Nat Rev Drug Discov (2003) 3.44
Imaging of light emission from the expression of luciferases in living cells and organisms: a review. Luminescence (2002) 2.01
Guided by the light: visualizing biomolecular processes in living animals with bioluminescence. Curr Opin Chem Biol (2009) 1.97
Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells (2007) 1.93
Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. J Biol Chem (1990) 1.86
Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer (2002) 1.67
11C-loperamide and its N-desmethyl radiometabolite are avid substrates for brain permeability-glycoprotein efflux. J Nucl Med (2008) 1.37
In vivo bioluminescence imaging. Comp Med (2004) 1.36
Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther (1997) 1.34
The anatomy of the normal placenta. J Clin Pathol (2008) 1.31
The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol (2007) 1.26
A dual-fluorescence high-throughput cell line system for probing multidrug resistance. Assay Drug Dev Technol (2009) 1.22
BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm Res (2008) 1.17
Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors. Am J Physiol Endocrinol Metab (2006) 1.16
The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies. Drug Metab Dispos (2010) 1.14
Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol (2006) 1.05
Structure of a multidrug transporter. Nat Biotechnol (2009) 1.04
Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol (2006) 1.02
Drug transport across the placenta, role of the ABC drug efflux transporters. Expert Opin Drug Metab Toxicol (2007) 1.02
Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979. Int J Cancer (2003) 1.01
Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta (2006) 1.01
Rapid detection of ABC transporter interaction: potential utility in pharmacology. J Pharmacol Toxicol Methods (2010) 0.99
Placental drug transporters. Curr Drug Metab (2004) 0.97
Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2. Proc Natl Acad Sci U S A (2013) 0.96
Placental drug transporters and their role in fetal protection. Placenta (2012) 0.95
Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primate. J Nucl Med (2009) 0.91
Active transport across the human placenta: impact on drug efficacy and toxicity. Expert Opin Drug Metab Toxicol (2006) 0.88
Overlapping substrate and inhibitor specificity of human and murine ABCG2. Drug Metab Dispos (2013) 0.88
Saturable active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier leads to nonlinear distribution of elacridar to the central nervous system. J Pharmacol Exp Ther (2013) 0.86
Positron emission tomography imaging of tissue P-glycoprotein activity during pregnancy in the non-human primate. Br J Pharmacol (2009) 0.85
Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation. Biosci Biotechnol Biochem (2005) 0.84
The use of optical imaging to assess the potential for embryo-fetal exposure to an exogenous material after intravaginal administration. Reprod Toxicol (2014) 0.83
The Inhibitor Ko143 Is Not Specific for ABCG2. J Pharmacol Exp Ther (2015) 0.82
Prenatal endotoxemia and placental drug transport in the mouse: placental size-specific effects. PLoS One (2013) 0.81
Placental P-glycoprotein is unaffected by timing of antenatal glucocorticoid therapy but reduced in SGA preterm infants. Placenta (2013) 0.80